Jane Street Group, LLC Aclaris Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 16, 2022	SELL	$10.16 - $17.08 $123,952 - $208,375	-12,200 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$9.74 - $17.92 $42,856 - $78,848	-4,400 Reduced 26.51%	12,200 $210,000
Q4 2021 Feb 15, 2022	BUY	$12.27 - $18.49 $36,810 - $55,469	3,000 Added 22.06%	16,600 $241,000
Q3 2021 Nov 16, 2021	SELL	$13.38 - $18.8 $100,350 - $141,000	-7,500 Reduced 35.55%	13,600 $245,000
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $61,487 - $106,560	3,600 Added 20.57%	21,100 $371,000
Q1 2021 May 18, 2021	BUY	$5.86 - $27.73 $102,550 - $485,275	17,500 New	17,500 $441,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $271M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.